Cargando…
Local Anti–PD-1 Delivery Prevents Progression of Premalignant Lesions in a 4NQO-Oral Carcinogenesis Mouse Model
Although the principle of systemic treatment to prevent the progression of oral premalignant lesions (OPL) has been demonstrated, there remains a lack of consensus about an optimal approach that balances clinical efficacy with toxicity concerns. Recent advances in cancer therapy using approaches tar...
Autores principales: | Shi, Yewen, Xie, Tong-xin, Leach, David G., Wang, Bingbing, Young, Simon, Osman, Abdullah A., Sikora, Andrew G., Ren, Xiaoyong, Hartgerink, Jeffrey D., Myers, Jeffrey N., Rangel, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8338806/ https://www.ncbi.nlm.nih.gov/pubmed/34021022 http://dx.doi.org/10.1158/1940-6207.CAPR-20-0607 |
Ejemplares similares
-
Genetic Changes Driving Immunosuppressive Microenvironments in Oral Premalignancy
por: Rangel, Roberto, et al.
Publicado: (2022) -
Premalignant Lesions in the Kidney
por: Kirkali, Ziva, et al.
Publicado: (2001) -
Immunostimulation and Immunoinhibition of Premalignant Lesions
por: Prehn, Richmond T
Publicado: (2007) -
Metabolic reprogramming of the premalignant colonic mucosa is an early event in carcinogenesis
por: Cruz, Mart Dela, et al.
Publicado: (2017) -
Mutant p53 drives an immune cold tumor immune microenvironment in oral squamous cell carcinoma
por: Shi, Yewen, et al.
Publicado: (2022)